| 1 | [SID103176092] | Active | Kd | 0.64 | Dissociation constant for binding to SH2 domain of p56 lck tyrosine kinase [AID224294, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Active | | Kd | 0.64 [uM] | | BioAssay | Dissociation constant for binding to SH2 domain of p56 lck tyrosine kinase | | AID | 224294 | | BioAssay type | Literature | | Target | | | PubMed | 10072676 | | Data Table |  |
|
| 2 | [SID103176092] | Active | Kd | 0.9 | Dissociation constant for binding to SH2 domain of Fyn protein kinase [AID72281, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Active | | Kd | 0.9 [uM] | | BioAssay | Dissociation constant for binding to SH2 domain of Fyn protein kinase | | AID | 72281 | | BioAssay type | Literature | | Target | | | PubMed | 10072676 | | Data Table |  |
|
| 3 | [SID103176092] | Active | | | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in GFP-fused DAF16 transcription factor mRNA expression at 50 ppm by quantitative RT-PCR analysis [AID452647, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Active | | BioAssay | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in GFP-fused DAF16 transcription factor mRNA expression at 50 ppm by quantitative RT-PCR analysis | | AID | 452647 | | BioAssay type | Literature | | Target | | | PubMed | 19837596 | | Data Table |  |
|
| 4 | [SID103176092] | Active | | | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in lifespan at 50 ppm by microscopic analysis [AID452626, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Active | | BioAssay | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in lifespan at 50 ppm by microscopic analysis | | AID | 452626 | | BioAssay type | Literature | | Target | | | PubMed | 19837596 | | Data Table |  |
|
| 5 | [SID103176092] | Active | | | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in DAF16 transcription factor mRNA expression at 50 ppm after 2 days by quantitative RT-PCR analysis [AID452627, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Active | | BioAssay | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in DAF16 transcription factor mRNA expression at 50 ppm after 2 days by quantitative RT-PCR analysis | | AID | 452627 | | BioAssay type | Literature | | Target | | | PubMed | 19837596 | | Data Table |  |
|
| 6 | [SID103176092] | Active | | | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as decrease in DAF2 receptor mRNA expression at 50 ppm after 2 days by quantitative RT-PCR analysis [AID452628, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Active | | BioAssay | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as decrease in DAF2 receptor mRNA expression at 50 ppm after 2 days by quantitative RT-PCR analysis | | AID | 452628 | | BioAssay type | Literature | | Target | | | PubMed | 19837596 | | Data Table |  |
|
| 7 | [SID103176092] | Unspecified | LD50 | 10 | Cytotoxicity against mouse RAW264.7 cells [AID627981, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | LD50 | 10 [uM] | | BioAssay | Cytotoxicity against mouse RAW264.7 cells | | AID | 627981 | | BioAssay type | Literature | | Target | | | PubMed | 21903399 | | Data Table |  |
|
| 8 | [SID103176092] | Unspecified | IC50 | 120 | Agonist activity at human FFA2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production [AID454554, Type: Literature] | Free fatty acid receptor 2 [gi:3122160] |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | IC50 | 120 [uM] | | BioAssay | Agonist activity at human FFA2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production | | AID | 454554 | | BioAssay type | Literature | | Target | Free fatty acid receptor 2 [gi:3122160] | | PubMed | 20005104 | | Data Table |  |
|
| 9 | [SID103176092] | Unspecified | | | Agonist activity at human FFA2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production relative to acetate [AID454564, Type: Literature] | Free fatty acid receptor 2 [gi:3122160] |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Agonist activity at human FFA2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production relative to acetate | | AID | 454564 | | BioAssay type | Literature | | Target | Free fatty acid receptor 2 [gi:3122160] | | PubMed | 20005104 | | Data Table |  |
|
| 10 | [SID103176092] | Unspecified | | | TP_TRANSPORTER: uptake (pH 7.4) of Acetic acid at a concentration of 4.94 u M in OATP-B-expressing HEK293 cells [AID679427, Type: other] | Solute carrier organic anion transporter family member 2B1 [gi:313104012] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | TP_TRANSPORTER: uptake (pH 7.4) of Acetic acid at a concentration of 4.94 u M in OATP-B-expressing HEK293 cells | | AID | 679427 | | BioAssay type | other | | Target | Solute carrier organic anion transporter family member 2B1 [gi:313104012] | | PubMed | | | Data Table |  |
|
| 11 | [SID103176092] | Unspecified | | | TP_TRANSPORTER: uptake (pH 5.0) of Acetic acid at a concentration of 4.94 u M in OATP-B-expressing HEK293 cells [AID679436, Type: other] | Solute carrier organic anion transporter family member 2B1 [gi:313104012] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | TP_TRANSPORTER: uptake (pH 5.0) of Acetic acid at a concentration of 4.94 u M in OATP-B-expressing HEK293 cells | | AID | 679436 | | BioAssay type | other | | Target | Solute carrier organic anion transporter family member 2B1 [gi:313104012] | | PubMed | | | Data Table |  |
|
| 12 | [SID103176092] | Unspecified | | | TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.00476 uM, acetic acid: 10000 uM) in OATP-B-expressing HEK293 cells [AID679446, Type: other] | Solute carrier organic anion transporter family member 2B1 [gi:313104012] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.00476 uM, acetic acid: 10000 uM) in OATP-B-expressing HEK293 cells | | AID | 679446 | | BioAssay type | other | | Target | Solute carrier organic anion transporter family member 2B1 [gi:313104012] | | PubMed | | | Data Table |  |
|
| 13 | [SID103176092] | Unspecified | | | TP_TRANSPORTER: uptake of Acetic Acid at a concentration of 6uM in MCT1-expressing MDA-MB231 cells [AID679837, Type: other] | Monocarboxylate transporter 1 [gi:1709076] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | TP_TRANSPORTER: uptake of Acetic Acid at a concentration of 6uM in MCT1-expressing MDA-MB231 cells | | AID | 679837 | | BioAssay type | other | | Target | Monocarboxylate transporter 1 [gi:1709076] | | PubMed | | | Data Table |  |
|
| 14 | [SID103176092] | Unspecified | | | Cytotoxicity against mouse RAW264.7 cells at 5 uM [AID627980, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against mouse RAW264.7 cells at 5 uM | | AID | 627980 | | BioAssay type | Literature | | Target | | | PubMed | 21903399 | | Data Table |  |
|
| 15 | [SID103176092] | Unspecified | | | Affinity for Vancomycin (Exp I) [AID227555, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Affinity for Vancomycin (Exp I) | | AID | 227555 | | BioAssay type | Literature | | Target | | | PubMed | 10579833 | | Data Table |  |
|
| 16 | [SID103176092] | Unspecified | | | Affinity for Vancomycin (Exp II) [AID227556, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Affinity for Vancomycin (Exp II) | | AID | 227556 | | BioAssay type | Literature | | Target | | | PubMed | 10579833 | | Data Table |  |
|
| 17 | [SID103176092] | Unspecified | | | Binding energy by using the equation deltaG obsd = -RT ln KD [AID227718, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Binding energy by using the equation deltaG obsd = -RT ln KD | | AID | 227718 | | BioAssay type | Literature | | Target | | | PubMed | 6094812 | | Data Table |  |
|
| 18 | [SID103176092] | Unspecified | | | Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system [AID237685, Type: Literature] | |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system | | AID | 237685 | | BioAssay type | Literature | | Target | | | PubMed | 15857133 | | Data Table |  |
|
| 19 | [SID103176092] | Unspecified | | | Dissociation constant, pKa of the compound [AID342464, Type: Literature] | |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Dissociation constant, pKa of the compound | | AID | 342464 | | BioAssay type | Literature | | Target | | | PubMed | 18570365 | | Data Table |  |
|
| 20 | [SID103176092] | Unspecified | | | Dissociation constant, pKa of the compound [AID448096, Type: Literature] | |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Dissociation constant, pKa of the compound | | AID | 448096 | | BioAssay type | Literature | | Target | | | PubMed | 19646864 | | Data Table |  |
|
| 21 | [SID103176092] | Unspecified | | | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as survival time at 50 ppm by fluorescent microscopy [AID452648, Type: Literature] | |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as survival time at 50 ppm by fluorescent microscopy | | AID | 452648 | | BioAssay type | Literature | | Target | | | PubMed | 19837596 | | Data Table |  |
|
| 22 | [SID103176092] | Unspecified | | | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in lifespan at 50 ppm by fluorescent microscopy relative to control [AID452649, Type: Literature] | |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in lifespan at 50 ppm by fluorescent microscopy relative to control | | AID | 452649 | | BioAssay type | Literature | | Target | | | PubMed | 19837596 | | Data Table |  |
|
| 23 | [SID103176092] | Unspecified | | | Toxicity in po dosed ICR mouse assessed as decreased in mobility after 3 hrs [AID498773, Type: Literature] | |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Toxicity in po dosed ICR mouse assessed as decreased in mobility after 3 hrs | | AID | 498773 | | BioAssay type | Literature | | Target | | | PubMed | 19465932 | | Data Table |  |
|
| 24 | [SID103176092] | Unspecified | | | Toxicity in po dosed mouse [AID498775, Type: Literature] | |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Toxicity in po dosed mouse | | AID | 498775 | | BioAssay type | Literature | | Target | | | PubMed | 19465932 | | Data Table |  |
|
| 25 | [SID103176092] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans [AID588211, Type: Literature] | |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans | | AID | 588211 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 26 | [SID103176092] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents [AID588212, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents | | AID | 588212 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 27 | [SID103176092] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents [AID588213, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents | | AID | 588213 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 28 | [SID103176092] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia [AID625279, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia | | AID | 625279 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 29 | [SID103176092] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis [AID625280, Type: Literature] | |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis | | AID | 625280 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 30 | [SID103176092] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis [AID625281, Type: Literature] | |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis | | AID | 625281 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 31 | [SID103176092] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis [AID625282, Type: Literature] | |   View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis | | AID | 625282 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 32 | [SID103176092] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests [AID625283, Type: Literature] | |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests | | AID | 625283 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 33 | [SID103176092] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure [AID625284, Type: Literature] | |   View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure | | AID | 625284 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 34 | [SID103176092] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis [AID625285, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis | | AID | 625285 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 35 | [SID103176092] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis [AID625286, Type: Literature] | |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis | | AID | 625286 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 36 | [SID103176092] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly [AID625287, Type: Literature] | |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly | | AID | 625287 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 37 | [SID103176092] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice [AID625288, Type: Literature] | |   View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice | | AID | 625288 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 38 | [SID103176092] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease [AID625289, Type: Literature] | |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease | | AID | 625289 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 39 | [SID103176092] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty [AID625290, Type: Literature] | |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty | | AID | 625290 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 40 | [SID103176092] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal [AID625291, Type: Literature] | |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal | | AID | 625291 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 41 | [SID103176092] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score [AID625292, Type: Literature] | |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score | | AID | 625292 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 42 | [SID103176092] | Unspecified | | | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in lifespan at 50 ppm by microscopic analysis relative to control [AID452629, Type: Literature] | |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in lifespan at 50 ppm by microscopic analysis relative to control | | AID | 452629 | | BioAssay type | Literature | | Target | | | PubMed | 19837596 | | Data Table |  |
|
| 43 | [SID103176092] | Unspecified | | | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in lifespan at 50 ppm after 2 weeks by microscopic analysis relative to control [AID452630, Type: Literature] | |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in lifespan at 50 ppm after 2 weeks by microscopic analysis relative to control | | AID | 452630 | | BioAssay type | Literature | | Target | | | PubMed | 19837596 | | Data Table |  |
|
| 44 | [SID103176092] | Unspecified | | | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of vit6 protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis [AID452631, Type: Literature] | |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of vit6 protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis | | AID | 452631 | | BioAssay type | Literature | | Target | | | PubMed | 19837596 | | Data Table |  |
|
| 45 | [SID103176092] | Unspecified | | | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of probable voltage-dependent anion-selective channel protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis [AID452632, Type: Literature] | |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of probable voltage-dependent anion-selective channel protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis | | AID | 452632 | | BioAssay type | Literature | | Target | | | PubMed | 19837596 | | Data Table |  |
|
| 46 | [SID103176092] | Unspecified | | | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of ATPA synthase subunit alpha, mitochondrial precursor protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis [AID452633, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of ATPA synthase subunit alpha, mitochondrial precursor protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis | | AID | 452633 | | BioAssay type | Literature | | Target | | | PubMed | 19837596 | | Data Table |  |
|
| 47 | [SID103176092] | Unspecified | | | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of aspartate aminotransferase protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis [AID452634, Type: Literature] | |   View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of aspartate aminotransferase protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis | | AID | 452634 | | BioAssay type | Literature | | Target | | | PubMed | 19837596 | | Data Table |  |
|
| 48 | [SID103176092] | Unspecified | | | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of nucleoside diphosphate kinase protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis [AID452635, Type: Literature] | |   View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of nucleoside diphosphate kinase protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis | | AID | 452635 | | BioAssay type | Literature | | Target | | | PubMed | 19837596 | | Data Table |  |
|
| 49 | [SID103176092] | Unspecified | | | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of mlc3 protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis [AID452636, Type: Literature] | |   View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of mlc3 protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis | | AID | 452636 | | BioAssay type | Literature | | Target | | | PubMed | 19837596 | | Data Table |  |
|
| 50 | [SID103176092] | Unspecified | | | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of mlc1 protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis [AID452637, Type: Literature] | |   View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103176092 | | CID | 176 | | Outcome | Unspecified | | BioAssay | Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of mlc1 protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis | | AID | 452637 | | BioAssay type | Literature | | Target | | | PubMed | 19837596 | | Data Table |  |
|